Can a smartphone app cut migraine days? new trial says yes

NCT ID NCT05616741

Completed Symptom relief Sponsor: Nordic Brain Tech AS Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a home-based biofeedback app called Cerebri in 279 adults with episodic migraine. Participants used the app daily for 10 minutes, along with sensors to track muscle tension, heart rate, and finger temperature. The goal was to see if this approach could reduce the number of migraine days compared to a wait-list group. The trial is complete and focused on safety and effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cerebri biofeedback device (app with sensors for muscle tension, heart rate, and temperature)
What this could lead to: If it works, this could offer a drug-free, at-home option to reduce migraine days for people with episodic migraine.
What could go wrong: This is a completed trial, but the effect may be modest and not work for everyone. Biofeedback requires daily commitment, and results may not apply to chronic migraine.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MIGRAINE

Contacts and locations

Locations

Akershus University Hospital HF

Lørenskog, Akershus, 1478, Norway
Haukeland University Hospital HF

Bergen, 5053, Norway
St.Olavs Hospital HF

Trondheim, Norway
University Hospital of North Norway

Tromsø, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.